Document Detail


Imbalance between thyroid hormones and the dopaminergic system might be central to the pathophysiology of restless legs syndrome: a hypothesis.
MedLine Citation:
PMID:  20535374     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Data collected from medical literature indicate that dopaminergic agonists alleviate Restless Legs Syndrome symptoms while dopaminergic agonists antagonists aggravate them. Dopaminergic agonists is a physiological regulator of thyroid-stimulating hormone. Dopaminergic agonists infusion diminishes the levels of thyroid hormones, which have the ability to provoke restlessness, hyperkinetic states, tremors, and insomnia. Conditions associated with higher levels of thyroid hormones, such as pregnancy or hyperthyroidism, have a higher prevalence of Restless Legs Syndrome symptoms. Low iron levels can cause secondary Restless Legs Syndrome or aggravate symptoms of primary disease as well as diminish enzymatic activities that are involved in dopaminergic agonists production and the degradation of thyroid hormones. Moreover, as a result of low iron levels, dopaminergic agonists diminishes and thyroid hormones increase. Iron therapy improves Restless Legs Syndrome symptoms in iron deprived patients. Medical hypothesis. To discuss the theory that thyroid hormones, when not counterbalanced by dopaminergic agonists, may precipitate the signs and symptoms underpinning Restless Legs Syndrome. The main cause of Restless Legs Syndrome might be an imbalance between the dopaminergic agonists system and thyroid hormones.
Authors:
Jose Carlos Pereira; Marcia Pradella-Hallinan; Hugo de Lins Pessoa
Related Documents :
19277834 - Absence of co-morbidity of parkinson disease and restless legs syndrome: a case-control...
3777014 - Toxic shock syndrome associated with tsst-1 producing coagulase-negative staphylococci.
7480294 - Toxic shock syndrome as a complication of breast prostheses.
21327144 - Cervical klippel-feil syndrome predisposing an elderly african man to central cord myel...
2184734 - Intestinal malabsorption syndromes.
18774664 - Agranulocytosis following phenytoin-induced hypersensitivity syndrome.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinics (São Paulo, Brazil)     Volume:  65     ISSN:  1980-5322     ISO Abbreviation:  Clinics (Sao Paulo)     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-06-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101244734     Medline TA:  Clinics (Sao Paulo)     Country:  Brazil    
Other Details:
Languages:  eng     Pagination:  548-54     Citation Subset:  IM    
Affiliation:
Departamento de Pediatria, Faculdade de Medicina de Jundiaí, São Paulo, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thalamic nuclear abnormalities as a contributory factor in sudden cardiac deaths among patients with...
Next Document:  Historical background and development of applied nutrition and community nutrition in Korea.